Principal Financial Group
RGNX icon

Principal Financial Group’s Regenxbio RGNX Stock Holding History

Principal Financial Group’s Portfolio RGNX Stock Details RGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-214,353
Closed -$2.25M – 2243
2024
Q3 		$2.25M Sell
214,353
-11,064
-5% -$135K ﹤0.01% 1750
2024
Q2 		$2.64M Buy
225,417
+9,206
+4% +$143K ﹤0.01% 1717
2024
Q1 		$4.56M Sell
216,211
-19,812
-8% -$353K ﹤0.01% 1600
2023
Q4 		$4.24M Sell
236,023
-2,327
-1% -$41K ﹤0.01% 1615
2023
Q3 		$3.92M Buy
238,350
+7,977
+3% +$145K ﹤0.01% 1611
2023
Q2 		$4.61M Sell
230,373
-11,653
-5% -$225K ﹤0.01% 1554
2023
Q1 		$4.58M Sell
242,026
-4,978
-2% -$110K ﹤0.01% 1558
2022
Q4 		$5.6M Buy
247,004
+2,974
+1% +$67.2K ﹤0.01% 1499
2022
Q3 		$6.45M Sell
244,030
-14,902
-6% -$442K 0.01% 1402
2022
Q2 		$6.4M Buy
258,932
+5,832
+2% +$146K ﹤0.01% 1464
2022
Q1 		$8.4M Sell
253,100
-2,430
-1% -$67.5K 0.01% 1474
2021
Q4 		$8.36M Sell
255,530
-14,307
-5% -$487K 0.01% 1487
2021
Q3 		$11.3M Buy
269,837
+13,591
+5% +$489K 0.01% 1339
2021
Q2 		$9.96M Buy
256,246
+186
+0.1% +$6.65K 0.01% 1433
2021
Q1 		$8.73M Buy
256,060
+33,858
+15% +$1.44M 0.01% 1453
2020
Q4 		$10.1M Buy
222,202
+1,063
+0.5% +$37.1K 0.01% 1219
2020
Q3 		$6.09M Sell
221,139
-28,786
-12% -$938K 0.01% 1363
2020
Q2 		$9.21M Buy
249,925
+6,531
+3% +$243K 0.01% 1109
2020
Q1 		$7.88M Sell
243,394
-9,604
-4% -$400K 0.01% 1040
2019
Q4 		$10.4M Buy
252,998
+571
+0.2% +$22.6K 0.01% 1226
2019
Q3 		$8.99M Sell
252,427
-4,165
-2% -$169K 0.01% 1260
2019
Q2 		$13.2M Buy
256,592
+891
+0.3% +$44.5K 0.01% 1076
2019
Q1 		$14.7M Buy
255,701
+6,076
+2% +$301K 0.01% 990
2018
Q4 		$10.5M Buy
249,625
+2,124
+0.9% +$125K 0.01% 1148
2018
Q3 		$18.7M Buy
247,501
+29,671
+14% +$2.14M 0.02% 899
2018
Q2 		$15.6M Buy
+217,830
New +$10.4M 0.01% 987

Other funds holding RGNX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Principal Financial Group's RGNX Position: Q4 2024 in Review

Principal Financial Group sold out of Regenxbio (RGNX) in Q4 2024, closing a stake of 214,353 shares — an estimated $2.25M sold.

Principal Financial Group first reported a position in RGNX in Q2 2018 and held it in 26 quarters. The position peaked at $18.7M in Q3 2018. 177 funds tracked by Wall St. Rank hold RGNX as of Q4 2024.

  • Principal Financial Group reported no remaining Regenxbio position as of Q4 2024 after selling out during the quarter.
  • Principal Financial Group sold 214,353 Regenxbio shares in Q4 2024, an estimated $2.25M.
  • Principal Financial Group first reported a position in Regenxbio in Q2 2018 and held it in 26 quarters.
  • Principal Financial Group's Regenxbio position peaked at $18.7M in Q3 2018.
  • 177 funds tracked by Wall St. Rank held Regenxbio as of Q4 2024.

Based on Principal Financial Group's 13F filing for Q4 2024, filed 31 Jan 2025.